2022
DOI: 10.3389/fgene.2022.919313
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic value of the ferroptosis-related gene SLC2A3 in gastric cancer and related immune mechanisms

Abstract: SLC2A3 is a ferroptosis marker engaged in transmembrane glucose transport. However, the effect of SLC2A3 on the prognosis of patients with cancer remains unclear. This study aimed to explore the prognostic implications of SLC2A3 and its underlying immune mechanisms in gastric cancer. The mRNA expression profiles and corresponding clinical data of patients with gastric cancer were downloaded from The Cancer Genome Atlas and Gene Expression Omnibus databases. Differentially expressed genes related to SLC2A3 were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 31 publications
0
4
0
Order By: Relevance
“…SLC2A3 may affect the immune response [ 17 ]. GSEA revealed that IL6/JAK/STAT3 signaling and interferon-γ response pathways were enriched in the upregulated genes in HNSC ( Figures 6a, 6b ).…”
Section: Resultsmentioning
confidence: 99%
“…SLC2A3 may affect the immune response [ 17 ]. GSEA revealed that IL6/JAK/STAT3 signaling and interferon-γ response pathways were enriched in the upregulated genes in HNSC ( Figures 6a, 6b ).…”
Section: Resultsmentioning
confidence: 99%
“…The results of this study and the reports from the literature indicate that the upregulated SLC2A3 is a ferroptosis marker involved in transmembrane glucose transport, and current studies on SLC2A3 have focused on cancer. Lin et al (2022) found that overexpression of SLC2A3 in tumor tissues is associated with poor prognosis in patients with gastric cancer. By immunohistochemical staining, SLC2A3 expression was found to be higher in colorectal cancer tissues than in adjacent nontumor colorectal mucosal tissues, and SLC2A3 could mediate the immune response by regulating EMT and PD-L1 (Gao et al, 2021).…”
Section: Discussionmentioning
confidence: 96%
“…54 SLC2A3 exerts multiple biological functions in different cancers, including tumor EMT, ferroptosis, glycolytic reprogramming, drug resistance and immunity. [55][56][57][58][59] Immune cell infiltration analysis showed that SLC11A1 and SLC2A3 expression was positively correlated with the infiltration levels of neutrophils, macrophages, dendritic cells, CD4+ T cells and CD8+ T cells. Moreover, the higher the expression levels of SLC11A1 and SLC2A3, the lower the tumor purity.…”
Section: Discussionmentioning
confidence: 99%
“…Reportedly, SLC11A1 not only predicts the prognosis of colorectal cancer and hepatocellular carcinoma 52,53 but also serves as a stratification indicator for immunotherapy or chemotherapy in glioma patients 54 . SLC2A3 exerts multiple biological functions in different cancers, including tumor EMT, ferroptosis, glycolytic reprogramming, drug resistance and immunity 55–59 . Immune cell infiltration analysis showed that SLC11A1 and SLC2A3 expression was positively correlated with the infiltration levels of neutrophils, macrophages, dendritic cells, CD4+ T cells and CD8+ T cells.…”
Section: Discussionmentioning
confidence: 99%